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Abstract
The phenotypic spectrum among girls with heterozygous mutations in the X-linked intellectual disability (XLID)
gene CASK (calcium/calmodulin-dependent serine protein kinase) includes postnatal microcephaly, ponto-cerebellar
hypoplasia, seizures, optic nerve hypoplasia, growth retardation and hypotonia. Although CASK knockout mice were
previously reported to exhibit perinatal lethality and a 3-fold increased apoptotic rate in the brain, CASK deletion
was not found to affect neuronal physiology and their electrical properties. The pathogenesis of CASK associated
disorders and the potential function of CASK therefore remains unknown. Here, using Cre-LoxP mediated gene
excision experiments; we demonstrate that deleting CASK specifically from mouse cerebellar neurons does not alter
the cerebellar architecture or function. We demonstrate that the neuron-specific deletion of CASK in mice does not
cause perinatal lethality but induces severe recurrent epileptic seizures and growth retardation before the onset of
adulthood. Furthermore, we demonstrate that although neuron-specific haploinsufficiency of CASK is
inconsequential, the CASK mutation associated human phenotypes are replicated with high fidelity in CASK
heterozygous knockout female mice (CASK(+/-)). These data suggest that CASK-related phenotypes are not purely
neuronal in origin. Surprisingly, the observed microcephaly in CASK(+/-) animals is not associated with a specific loss
of CASK null brain cells indicating that CASK regulates postnatal brain growth in a non-cell autonomous manner.
Using biochemical assay, we also demonstrate that CASK can interact with metabolic proteins. CASK knockdown in
human cell lines cause reduced cellular respiration and CASK(+/-) mice display abnormalities in muscle and brain
oxidative metabolism, suggesting a novel function of CASK in metabolism. Our data implies that some phenotypic
components of CASK heterozygous deletion mutation associated disorders represent systemic manifestation of
metabolic stress and therefore amenable to therapeutic intervention.
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Introduction
CASK is an evolutionarily conserved gene which en-
codes for a member of the membrane-associated guany-
late kinase (MAGUK) protein family [31]. In mammals
CASK was discovered due to its ability to bind to the
cytosolic tail of neuronal adhesion molecules neurexins
and therefore is primarily identified as a scaffolding pro-
tein at the neuronal synapse [21]. However, CASK dele-
tion does not alter synapse formation in C. elegans [25],
Drosophila [56] or mouse [3]. CASK ortholog lin-2 was
identified in C. elegans as early as 1980 and was found
in screens for cell lineage specificity rather than synaptic
function [16, 24]. Although CASK is essential for sur-
vival in mouse, detailed electrophysiological analysis on
CASK null mice failed to uncover changes in core neur-
onal functions such as membrane excitability, calcium-
dependent pre-synaptic release or post-synaptic receptor
organization [3]. In fact, CASK evolved before the emer-
gence of the nervous system [31, 43] and is present in
tissues from all three germ layers in mammals [21, 60].
Within the brain, CASK is expressed by neurons and
non-neuronal cells such as oligodendrocytes [2] and
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astrocytes [36]. The phylogenetic data and tissue distri-
bution of CASK, together with the phenotypes of CASK-
mutated animal models, strongly suggest that CASK
may have an important but currently ill-defined non-
synaptic function(s). In fact, CASK has been noted to
play a role in wide variety of cellular functions including
transcription regulation [27], insulin signaling and secre-
tion [67, 72], and cancer biology [68].
Subjects with mutations in CASK exhibit autistic
traits, intellectual disability [20], Ohtahara syndrome
[51], infantile spasms [40], FG syndrome [48], mental re-
tardation and microcephaly with pontine and cerebellar
hypoplasia (MICPCH) [45, 47, 64]. In addition, CASK
mutations are associated with growth retardation, optic
nerve hypoplasia/ atrophy, epilepsy, sensorineural deaf-
ness and hypotonia often resulting in scoliosis [8, 42].
This symptomatology is strikingly similar to that of
metabolic diseases [38]. Mitochondrial respiratory chain
defects and mutations in mitochondrial proteins are
often associated with cerebellar hypoplasia [14, 34].
Mitochondrial diseases frequently affect the optic nerve
and auditory sensory circuits (reviewed in [9, 55]). More-
over, epilepsy and hypotonia are primary manifestations
in mitochondrial encephalopathies [30, 61]. Syndromes
associated with CASK mutations, e.g. Ohtahara syn-
drome, can also arise from respiratory chain defects [10,
69]. Recently, we found that CASK interacts with mito-
chondrial proteins in Drosophila melanogaster, pointing
to a potential role of CASK in the regulation of metabol-
ism [44].
A large component of CASK-associated pathology de-
velops postnatally, which has been reported by some au-
thors as postnatal microcephaly or even atrophy [41].
Consistent with this idea, the brain of CASK null mice is
normal at birth and properly laminated, and no defect in
synapse formation is detectable [3]; deletion of CASK
does, however, lead to an increased apoptotic rate in the
mouse brain by 3-folds [3], which might easily explain
the postnatal microcephaly. Since CASK constitutive
knockout mice die within a few hours after birth, further
analysis has not been possible.
Here, we demonstrate that the cerebellar hypoplasia
caused by CASK heterozygous deletion mutation is not
due to the loss of CASK gene specifically in cerebellar
neurons. In fact, some of the MICPCH phenotypes may
be primarily due to a non-neuronal function of CASK.
Mice that are heterozygous for CASK deletion in neu-
rons appear normal, but the constitutive whole-body
heterozygous knockout (CASK(+/-)) female mice pheno-
copy the human disease state, indicating that MICPCH
occurs due to an overall haploinsufficiency of the CASK
gene. Surprisingly, the observed microcephaly in
CASK(+/-) mice is not simply due to loss of only the
CASK null cells i.e. it occurs in a non-cell autonomous
manner. We further demonstrate that CASK interacts
with mitochondrial proteins and that CASK(+/-) mice ex-
hibit metabolic defects. Knocking down CASK expres-
sion in a human cell line recapitulates these defects.
These findings indicate that mammalian CASK has a
novel role in metabolic regulation which is crucial for
postnatal brain growth in mammals.
Materials and methods
Generation of CASK(+/-) heterozygous and CASK neuronal
knockout mice
CASK(+/floxed) female mice were crossed with male mice
carrying a transgenic Cre recombinase controlled by the
zona pellucida 3 promoter [33]. The F1 generation off-
springs were genotyped to identify female mice carrying
the Cre recombinase and the floxed CASK gene. These
female mice were crossed with wild-type C57Bl6 male
mice to obtain female CASK(+/-) mice. Crossings were
continued with wild-type male mice to eliminate the Cre
transgene. Colonies were maintained as CASK(+/-) fe-
males. CASK neuronal knockout mice were generated by
crossing the CASK(+/floxed) female mice with a mouse
line expressing Cre recombinase under the control of
synapsin 1 promoter [71]. Male mice from the F1 gener-
ation bearing the Cre transgene and floxed CASK were
analyzed. A table providing information on all mice used
is shown in Additional file 1: Figure S1A.
Generation of CASK knockdown cells
HEK 293 cells were transduced with PLKO lentiviral
particles carrying CASK shRNA or empty lentiviral par-
ticles. Experiments were performed 96 h post-
transduction. Cell homogenates were analyzed for CASK
expression using quantitative immunoblotting.
Mitochondrial respiration measurements
Mitochondrial oxygen consumption was measured in
whole brain homogenates using the conventional Clark
electrode assay as previously described [11]. Briefly, total
respiration was measured in a buffer containing 0.3 M
mannitol, 10 mM KCl, 5 mM MgCl2, 10 mM KH2PO4
and 1 mg/ml BSA (pH 7.4) in a water-jacketed cell mag-
netically stirred at 37 °C (Hansatech instruments, Nor-
folk, UK). Oxygen consumption rates were measured
both in the presence and absence of potassium cyanide
(KCN) to assess the rate of KCN sensitive respiratio-
n.Oxygen consumption measurements from HEK 293
cells were done as previously described [58, 59]. Briefly,
HEK 293 cells were trypsinized and harvested in a
sucrose-containing buffer (25 mM Tris–HCl, 10 mM
K2HPO4 and 150 mM sucrose (pH 7.4)). Oxygen con-
sumption in cell suspensions were measured in a water-
jacketed cell magnetically stirred at 37 °C (Hansatech in-
struments, Norfolk, UK).
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Immunoblotting
Samples were separated by 10 % SDS-PAGE, transferred
to nitrocellulose, blocked in 5 % skimmed milk for 2 h
and incubated with primary antibody for 1 h followed by
incubation with secondary antibody (1:5000 dilution) for
30 min at room temperature. The chemiluminescent sig-
nal was detected via the enzymatic reaction using ECL
detection reagents (Amersham) and visualized on Che-
miDoc (Biorad). For quantitative immunodetection, the
blots were incubated with a fluorescent secondary anti-
body (Alexa 488) for 30 min at room temperature. The
primary antibodies used included anti-ATP synthase
subunit β (MitoSciences MS503, 1:1000), anti-
synaptophysin (Sigma, 1:1000), anti-tubulin (DSHB,
1:1000), anti-CASK (Neuromab, 1:1000), and anti IDH
(AssayBiotech, 1:1000).
Energy expenditure and respiratory exchange ratio
measurements
The energy expenditure and respiratory exchange ratios
were measured over 48 h using the indirect calorimetry
(TSE Systems, Chesterfield, MO). Energy expenditure
data were expressed relative to free fat mass and pre-
sented as mean ± SEM. The TSE system is equipped with
beams pointing in the horizontal (X,Y) and vertical (Z)
directions. As mice break these beams, the LabMaster
software sums this movement, which is translated into
cage activity expressed as meters/hr.
Protein quantitation
All protein quantitations were done using the Coomassie
Bradford reagent from Biorad, following the manufac-
turer’s instruction.
Brain sectioning and immunofluorescent staining
Animals were deeply anesthetized to avoid any pain and
sacrificed mechanically either by decapitation or exsan-
guination. All animal procedures were performed in ac-
cordance with the Virginia Tech guidelines for use and
care of laboratory animals. Three-month-old mature
adult mice were deeply anaesthetized using isoflurane,
and mice hearts were cannulated and perfused with PBS
(exsanguination) followed by 4 % paraformaldehyde
(PFA). The perfused mice were decapitated and brains
were dissected out and fixed in 4 % PFA overnight.
Brains were cryopreserved by incubation in 30 % sucrose
solution for 48 h. For sectioning, brains were embedded
in CryoTek™ and 20 μm-thick cortical sections were gen-
erated using a cryostat (IEC). The cortical sections were
immunostained as floating sections. Sections were
permeabilized with 0.025 % Triton X-100 followed by
blocking with 5 % goat serum. Sections were stained
with primary antibodies for two hours followed by sec-
ondary antibody (1:500) incubation for 30 min. Finally,
sections were mounted on slides using PermaFluor™
mounting medium (Thermo Scientific) and coverslips
were sealed using nail polish.
Fatty-acid and glucose oxidation assays
Fatty-acid oxidation was assessed in the mouse brain,
red and white gastrocnemius muscle and quadriceps
femoris muscle by measuring and summing 14CO2 pro-
duction and 14C-labeled acid-soluble metabolites from
the oxidation of [1-14C]-palmitic acid (American Radi-
olabeled Chemicals, St. Louis MO) respectively. Briefly,
samples were incubated in 0.5 μCi/ml of [1-14C]-palmitic
acid for 3 h. Media was then removed and exposed to
45 % perchloric acid for 1 h to liberate 14CO2, which
was trapped in a tube containing 1 M sodium hydroxide
(NaOH). The NaOH was then placed into a scintillation
vial with 5 ml scintillation fluid added. The vial was then
placed on a scintillation counter (LS 4500, Beckman
Coulter) and counted for the presence of 14C. Acid sol-
uble metabolites were determined by collecting the acid-
ified media and measuring 14C content. Glucose
oxidation was assessed by measuring 14CO2 production
in a similar manner to fatty acid oxidation with the ex-
ception that [U-14C]-glucose was substituted for [1-14C]-
palmitic acid.
Body composition measurement
Body composition was measured using Burker mini spec
LF90, as previously described [39].
Glutathione-S-transferase (GST) pull down assay
GST-fusion CASK and GST were expressed in the
BL21-DE3 strain of E. coli and purified by affinity chro-
matography on a glutathione–Sepharose column (Amer-
sham) [18]. GST-pulldowns from rat brain were
performed essentially as described [37].
Triton X-114 phase separation of homogenized mouse
brain
Triton X-114 phase separation protocol was based on a
previously published method [7]. Briefly, 4 % Triton X-
114 (Sigma) in PBS containing protease inhibitors was
mixed 1:1 with brain homogenate. The mixture was first
incubated on ice for 10 min and then incubated at 37 °C
for 10 min to promote separation of two phases. The
sample was then centrifuged at 25 °C for 10 min at
13,000 g for separation into 1) aqueous phase on top, 2)
a detergent phase in the middle, and 3) a pellet at the
bottom.
Linear glycerol gradient centrifugation
A continuous glycerol gradient (10 % - 40 %) was gener-
ated using a Gradient Master™ (BioComp Instruments,
Inc.) containing 25 mM HEPES-NaOH, pH 7.2, 150 mM
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NaCl, 5 mM DTT, 2 mM EDTA and protease inhibitors
On a 10 mL continuous glycerol gradient buffer in ultra-
centrifuge tubes used with SW41 Ti Rotor (Beckman
Coulter), 0.5 mL of the aqueous phase from the Triton
X-114 phase separation of homogenized brain was care-
fully layered and then centrifuged for 20 h, at
35,000 rpm at 4 °C. A total of 9 fractions (1.1 mL each)
were collected using the Piston Gradient Fractionator
(BioComp Instruments, Inc.). Separate tubes were used
for recombinant CASK protein and protein standards in
the same experiment.
Brain subcellular fractionation and solubilization
Subcellular fractionation was performed similar to previ-
ous publication [11]. Briefly, dissected brains were rap-
idly transferred to ice cold homogenization buffer (i.e.
0.32 M sucrose and 20 mM HEPES pH 7.4 with protease
inhibitors). The brain was homogenized in a motorized
homogenizer (~20 strokes). Brain homogenates were
centrifuged at 1000 g for 10 min to generate post nu-
clear supernatant (PNS). The PNS was centrifuged at
17,000 g for 15 min to obtain a pellet, which was subse-
quently washed once with homogenization buffer and
then resuspended in homogenization buffer to obtain
crude synaptosomes. Crude synaptosomes were sub-
jected to ultracentrifugation (120,000 g). The super-
natant was filtered through a 200 μm filter to obtain
cytosolic fraction. The pellet was first solubilized in PBS
containing 1 % Triton X-100 and protease inhibitors for
two hours to obtain a Triton X-100-soluble fraction. The
remaining pellet was further solubilized in PBS contain-
ing 1 % deoxycholic acid and protease inhibitors at 4 °C.
Force plate actometry and rotarod treadmill experiments
For force plate analyses, the adult littermate mice per geno-
type performed on a force plate (Bioseb) for 5 min as de-
scribed previously [22]. Ataxic index was calculated as the
area traveled over the distance covered on the force plate.
We also tested the ability of mice to balance on a fixed
speed rotarod test (10RPM) (Ugobasile). Each mouse was
given three runs each day and an average was calculated.
Results
Cerebellar neuron-specific deletion of CASK does not produce
cerebellar hypoplasia
Heterozygous deletion mutations in CASK produce cere-
bellar hypoplasia [8, 45]. It has also been demonstrated
that mice carrying a floxed CASK gene (CASKfloxed)
express ~ 33 % CASK compared to the wildtype
littermates, and exhibit hypoplasia of cerebellar vermis
[3, 45]. These data indicate that CASK may play a crucial
role in the cerebellum. We therefore decided to use the
Cre-loxP method to specifically delete CASK from cere-
bellar neurons. In order to ascertain the validity of this
methodology, we first produced neuron-glia mixed cultures
from P1.5 (postnatal day 1.5) CASKfloxed mice and trans-
duced them with Cre-expressing lentivirus. Immunoblotting
revealed that Cre expression specifically and completely
eliminated CASK expression in these cultures within 96 h of
virus addition. (Additional file 1: Figure S1B,C).
First, CASK expression was deleted from Purkinje cells
-the major output neurons involved in motor coordination
by crossing a CASKfloxed mouse line to a PCP2 (Purkinje
cell protein 2)-Cre transgenic line [4]. Deleting CASK from
Purkinje cells did not alter the arrangement or morphology
of these cells (Fig. 1a, b, c). We analyzed the locomotion of
these mice both in their home cage as well as on a rotarod.
Mice lacking CASK in Purkinje cells exhibited no locomo-
tory phenotype that could be interpreted as ataxic, suggest-
ing that CASK is not required for the survival and
functioning of Purkinje cells (Fig. 1d, e, f, g).
We next deleted CASK from the cerebellar granule
cells by crossing the CASKfloxed mouse line to a Math5-
Cre transgenic line. Math5-Cre is expressed in many dif-
ferent areas of brain including the hippocampus, the
fourth layer of the cortex and the cerebellar cortex. In
the cerebellum, cells expressing Math5-Cre give rise to
the tightly packed cells in the granular layer [70]. We
confirmed this distribution by crossing the Math5-Cre
mouse line to an indicator mouse line that expresses
tdTomato in a Cre-dependent manner [35]. Our experi-
mental results show that Math5-Cre is expressed in
granular cells as well as in a few cells in the molecular
layer (Fig. 1h, middle panels). Granular cells are formed
in the external granular layer during cerebellar genesis
and subsequently migrate inwards. The CASK null
granular cells are capable of this migration as indicated
by their proper localization in the adult mouse cerebellum
(Fig. 1h, lower row). Furthermore, we found that deleting
CASK from the cerebellar granule cells did not alter the
size of the cerebellum or layering of neurons compared to
the CASKfloxed mice (Fig. 1i, j, k). No specific motor defi-
cits were observed in any of these mice (data not shown).
Our data therefore imply that although CASK may play an
important role in cell survival in the postnatal brain, delet-
ing it from specific neuronal subtypes is compatible with
their survival. Furthermore, our data indicates that the
cerebellar hypoplasia phenotype observed in CASK muta-
tion subjects may not be directly related to the loss of
CASK function in cerebellar neurons.
MICPCH pathology is not purely neuronal in origin
CASK knockout mice exhibit perinatal lethality and
heightened apoptotic rates in the brain, indicating that
CASK is essential for ex utero survival of brain cells [3].
However, our cerebellum-specific deletion experiments
suggest that CASK may not be important for cell-
autonomous survival. A large body of literature suggests
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Fig. 1 (See legend on next page.)
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that CASK may have a potential synaptic function
(Reviewed in [26]), abnormality in which may lead to
death of brain cells. Previously, attempt to generate
brain specific CASK knockout mice was done using a
transgenic mice expressing cre recombinase driven by
nestin promoter to delete CASK from embryonic brain.
The resultant mice exhibited perinatal lethality like the
constitutive CASK knockout mice (personal communica-
tion with Prof. Susanne Schoch McGovern). However
besides neurons, nestin is also expressed in non-
neuronal brain cells and even in extra-neuronal tissue
which made it difficult to interpret this data [65, 66]. We
have therefore generated the pan-neuronal-specific
CASK knockout mice by crossing CASKfloxed mice [3]
with a synapsin1-Cre line which expresses Cre exclu-
sively in post-mitotic neurons [54, 71]. In parallel, we
also crossed the synapsin-Cre mice with the reporter
mouse line that expresses tdTomato in a Cre-dependent
manner. Our experiments confirmed the previous find-
ings that Cre-mediated recombination in these mice oc-
curs in nearly all neurons at an embryonic stage (as
early as E12.5) ([71] and Additional file 1: Figure S2A,B).
Since most CASK-associated patients are females har-
boring a heterozygous mutation in CASK, we initially
examined female mice heterozygous for deletion of
CASK pan-neuronally. Surprisingly, female mice hetero-
zygous for neuron-specific CASK deletion exhibit no
major phenotype and have normal-sized brains, includ-
ing the cerebellum (Additional file 1: Figure S2C,D,E,F).
This observation strongly suggests that CASK-associated
MICPCH in humans is not specifically a neuronal path-
ology. Consistent with this assumption, complete dele-
tion of CASK from all neurons did not produce the
neonatal lethality observed in the constitutive CASK
knockout mice [3] (Fig. 2a). The CASK neuronal-null mice
are indistinguishable from their wild-type littermates until
~ 10 - 12 days after birth and maintain mobility until
21 days after birth, indicating that they have functional
synapses (Additional file 2: Movie S1). After 10 days of
birth, the CASK neuronal-null mice begin to exhibit a
slower growth rate and by ~ 20 days of age, CASK
neuronal-null mice are less than half the size of the con-
trol CASKfloxed mice or wild-type littermates (Fig. 2b).
Brain weight is also significantly reduced in the CASK
neuronal knockout pups, although the cerebellum appears
normal compared to CASKfloxed mice and wildtype mice
(Fig. 2c and Additional file 1: Figure S3). True microceph-
aly has been defined by some studies as an adult brain
which is not only small but small for body weight [13, 23].
We therefore next measured the ratio of brain weight to
body weight in CASK neuronal-null mice. The brain
weight to body weight ratio is however significantly in-
creased in the CASK neuronal-knockout mice compared
to the control CASKfloxed mice or wildtype mice (Fig. 2d
and data not shown), suggesting that the reduction in
brain weight is secondary to overall growth retardation.
Brain lamination is unaltered, and the neuronal arrange-
ment in CASK neuronal knockout hippocampi and cere-
bella are comparable to control mice (Fig. 2e and
Additional file 1: Figure S3). Neuronal CASK knockout
mice express ~ 15 % of wild-type CASK in the brain
(Fig. 2f, g), which may be due to CASK expression in other
cell types including astrocytes [36] and oligodendrocytes
[2]. Although CASK is deleted from most neurons at the
embryonic stage, the levels of pre-synaptic and post-
synaptic markers are unchanged, consistent with the previ-
ous study that demonstrated synapse formation is unaltered
in CASK knockout mice [3]. The level of glial fibrillary
acidic protein (GFAP) is also unaltered, indicating that al-
though CASK is specifically deleted in neurons, there is no
reactive gliosis and the ratio of neurons to astroglia may be
unaltered (Fig. 2f, g). Beginning around 17-18 days of age,
these mice suffer from progressively increasing bouts of
epileptic seizures and spasms, which often prove fatal be-
fore 23 - 24 days of age (Additional file 3: Movie S2). Inci-
dentally, epileptic spasms and epileptic disorders have
been demonstrated in patients with CASK mutations [46,
51]. It has to be however considered that the CASK
(See figure on previous page.)
Fig. 1 CASK deletion from Purkinje cells or granule cells does not alter cerebellar development. a Representative brain sections from two months
old control mice carrying a floxed CASK gene (XflCASK/Y) and mice with CASK knocked out from Purkinje cells (XflCASK/Y; PCP2-cre); sections are
stained with green (nucleic acid stain) and red (calbindin). Arrows indicate Purkinje cells. b Quantitation of molecular layer thickness and (c)
Quantitation of Purkinje cell diameter; data are plotted as mean ± SEM, n = 3 mice. d, e, f Locomotion of mice analyzed in home cage using an
overnight force plate experiment indicating no obvious change in locomotion. Average speed, average highest speed and average % activity are
quantified and data are plotted as mean ± SEM, n = 3 mice. g Quantitation of retention time of mice on fixed speed rotarod, data are plotted as
mean ± SEM, n = 4 mice. Floxed indicates CASKfloxed mice and PCKO indicates Purkinje cell-specific CASK knockout mice. h Representative brain
sections from two month old mice with indicated genotypes showing that CASK deletion from cerebellar granule cells does not lead to neuronal
death or alteration in layering. LSL-tdTomato is a Cre indicator line in which a loxP-flanked stop cassette prevents expression of a red fluorescent
protein; Math5-Cre mouse line has Cre recombinase expressed under the Math5 promoter. Arrows indicate inner granular layer where Cre-
recombinase is expressed. Please note that the top two panels are cerebellar sections from mice with unperturbed CASK gene. i Representative brain
images of two month old mice with indicated genotype. j Parasaggital sections of cerebellum showing that CASK deletion from granule cells does not
lead to cerebellar hypoplasia. k Quantitation of cerebellar area in parasagittal sections; data are plotted as mean ± SEM, n = 3. Floxed indicates
CASKfloxed mice and GCKO indicates granule cell-specific CASK knockout mice
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neuronal-null mice are produced on the CASKfloxed mice
background, so glial cells are generating only ~ 33 % of
CASK. The strong phenotype in the CASK neuronal-null
mice therefore may indicate a combination of effect from
CASK-null neurons and CASK-hypomorphic glial cells.
Altogether, these data suggest that although loss of CASK
function in neurons contributes to some components of
the phenotypic spectrum of CASK-associated pathology
(e.g. growth retardation and epilepsy), it does not contrib-
ute to microcephaly or cerebellar hypoplasia. Many CASK
missense mutations in human males are associated with
intellectual disabilities and growth retardation in the ab-
sence of microcephaly, clearly indicating that these pheno-
types are not interdependent and may represent loss of
different molecular functions of CASK [20].
CASK(+/-) mice mimic the human MICPCH phenotype
Since CASK-related neurological disorders occur due to
deletion of a single CASK allele in females, we engi-
neered a CASK(+/-) mouse line to model the neurodeve-
lopmental defects. (Methods section and Additional file
1: Figure S4). Similar to the CASK(-/-) complete knock-
out mice, the brains of CASK(+/-) knockout mice were
indistinguishable from their wild-type littermates at birth
(Fig. 3a) [3]. However, pronounced microcephaly was
observed beginning one week after birth, and the brains
of adult CASK(+/-) females were ~ 25 % smaller in weight
compared to sex-matched wild-type littermate controls
(Fig. 3a, b). The hematoxylin and eosin (H&E) staining
of brain sections showed no significant change in hippo-
campal size and layering of cells in the CASK(+/-) mice
(Fig. 3c, g), but a marked decrease in cerebellar size
(Fig. 3d, g) and number of cells in the cerebellum
(Fig. 3e) was observed in the CASK(+/-) mice compared
to the CASK(+/+) mice, suggesting disproportionate cere-
bellar hypoplasia. In contrast to lissencephaly [17], the
CASK(+/-) cerebellum exhibited normal layering of cells
(Fig. 3c, d, e). Examination of the cerebella of 5-day-old
CASK(+/-) mice revealed that the thickness of the exter-
nal granular layer (where granule cells are formed) re-
mains unchanged (Additional file 1: Figure S5A,B).
These data are consistent with our previous findings that
lack of CASK increases cell loss by apoptosis rather than
by producing any deficiency in the formation of cells [3].
Similar to CASK heterozygous deletion mutation pa-
tients, the CASK(+/-) mice displayed optic nerve hypopla-
sia (ONH); the optic nerve diameter was significantly
reduced compared to sex-matched CASK(+/+) littermate
controls (Fig. 3f, g). Although we observed a trend to-
wards microphthalmia in CASK(+/-) mice, the optic globe
size difference did not reach a statistical significance
(Fig. 3g). ONH is frequently accompanied by malforma-
tion of the brain midline [5], but we did not observe
such an anomaly in the CASK(+/-) mice (Additional file
1: Figure S6A), suggesting that ONH associated with
CASK heterozygous deletion mutation has a distinct
pathology. Similar to CASK patients, CASK(+/-) mice dis-
play scoliosis with a high degree of penetrance (~85 %)
(Fig. 4a). CASK(+/-) mice also readily display a hind-limb
clasping phenotype (Fig. 4b) that is indicative of neuro-
logical and motor dysfunction [19]. Atypical limb clasp-
ing phenotype involving four-limb clasping was also
frequently observed. We did not find any anatomical ab-
errations in peripheral nerves such as myelination de-
fects (data not shown) or neuromuscular junction
abnormalities (Additional file 1: Figure S6B), which indi-
cates that both hypotonia and the hind-limb clasping
phenotype most likely originate from central nervous
system impairment. CASK(+/-) mice also display in-
creased diurnal activity relative to their sex-matched
wild-type littermate controls (Fig. 4c) and are ataxic.
CASK(+/-) mice fall off a rotarod much earlier (<2 min)
than control mice (~6 min) due to ataxia in the first two
days of training. Upon repeated training, however, these
mice exhibit motor learning (Fig. 4d). Ataxia in mice can
also be visualized by tracking movements within their
home cage using a force plate. We observed that the
CASK(+/-) mice traveled a longer distance to cover the
same area compared to the CASK(+/+) mice (Fig. 4e, f), a
parameter that is indicative of a higher ataxic index [22]. In
sum, these data suggest that CASK(+/-) mice recapitulate
multiple phenotypes observed in patients with MICPCH
(See figure on previous page.)
Fig. 2 Survival and normal brain formation in CASK neuronal knockout mice. a Shows the expected (grey bar) and observed (black bar)
percentage of mice with each genotype obtained from crossing the X/Y;synapsin-Cre males with XflCASK/X females; n = 62. Arrow indicates the
neuronal CASK knockout group. b Weight of CASKfloxed (floxed) and neuronal CASK knockout male mice (NKO) at 20 days of age.
(* indicates p < 0.05; n = 5) (c) Representative brain halves and brain weight at 21 days of age from CASK (XflCASK/Y) (floxed) and neuronal CASK
knockout (NKO) mice. (* indicates p < 0.05; n = 4). d Ratio of brain to body weight of CASK (XflCASK/Y) (floxed) and neuronal CASK knockout mice
(NKO). (* indicates p < 0.05; n = 4). e Image showing hippocampus from 21 day old CASKfloxed and CASK neuronal knockout mice. Green staining
indicates nucleic acid and red staining indicates synaptophysin. Note that there is no significant change in the lamination and CA3 region
synaptophysin staining in CASK neuronal knockout mice. f Representative Western blot showing endogenous levels of CASK, PSD95,
synaptophysin and tubulin from 21 day old mice. g Western blot protein quantitation where data is normalized to tubulin and expressed relative
to wild-type levels. Bar graphs are plotted as mean ± SEM. (* indicates p < 0.05; n = 3). Wild-type represents littermate mice with unperturbed CASK
gene, floxed indicates CASKfloxed mice and NKO indicates neuron-specific CASK knockout mice











































































Fig. 3 (See legend on next page.)
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and therefore MICPCH represents heterozygous loss of
CASK function (i.e. functional haploinsufficiency).
CASK deletion affects cell number in a non-cell-
autonomous manner
Although CASK(-/-) homozygous deletion has been
shown to enhance the rate of apoptosis by nearly 3-fold
in the brain [3], deleting CASK specifically from neur-
onal cells revealed that CASK is not essential for
neuronal survival in a cell-autonomous manner (Figs. 1
& 2). We therefore next sought to determine if the
microcephaly in CASK(+/-) mice was due to a reduction
in cell number in a non-cell-autonomous manner. CASK
is an X-linked gene and hence subject to random inacti-
vation, therefore brains from female mice with a
CASK(+/-) genotype are mosaic for CASK expression,
with ~ 50 % of brain cells not expressing CASK. Cell
death specifically of CASK-deleted brain cells in a
(See figure on previous page.)
Fig. 3 CASK(+/-) heterozygous mutant mice display postnatal microcephaly, cerebellar hypoplasia and optic nerve hypoplasia. a Representative
brain images of the sex-matched CASK(+/+) and CASK(+/-) mutant littermates at postnatal day 1 and day 75 (P1 and P75), respectively. b
Quantitation of brain weights from CASK(+/+) and CASK(+/-) mice at P1 and P75 (* indicates p < 0.05; n = 4). c Hematoxylin and eosin (H&E) stained
sections of hippocampus derived from CASK(+/+) and CASK(+/-) mice at P75; note the hippocampi sizes are comparable. d H&E stained sections of
the cerebellum at P75 showing pronounced cerebellar hypoplasia in CASK(+/-) mice relative to the CASK(+/+) control. e High magnification of the
indicated square regions from panel D showing relatively fewer cells in the cerebellar folia of CASK(+/-) mice compared to the CASK(+/+) control.
f Left panel shows representative images of the optic globe and optic nerve derived from three month old CASK(+/+) and CASK(+/-) mice . Right
panel shows the optic nerve cross section stained with anti-tubulin antibody from CASK(+/+) and CASK(+/-) mice; note the decrease in optic nerve
diameter . Scale bar = 100 μm. g Quantification of the cerebellar and hippocampal areas and the optic nerve and optic globe diameters obtained
from CASK(+/+) and CASK(+/-) mice. Measurements were made using Image J software and normalized to the sex-matched wild-type littermate
controls. Bar graphs are plotted as mean ± SEM; (* indicates p < 0.05; n = 4)













































































Fig. 4 CASK(+/-) mice display musculoskeletal and locomotion defects. a Dissected torso from three month old CASK(+/+) and CASK(+/-) mice;
CASK(+/-) mice display scoliosis. b CASK(+/-) mice display hind-limb clasping phenotype. c Activity of CASK(+/+) and CASK(+/-) mice measured in
metabolic cages. Data plotted as mean ± SEM; (* indicates p < 0.05; n = 5) (d) CASK(+/-) mice were trained on a fixed speed rotorod and retention
time noted. On each day, fresh sets of sex-and-age matched CASK(+/+) littermate mice were used as controls. Data are plotted as mean ± SEM;
(* indicates p < 0.05; n = 5). e Representative 5-min trace of positions of CASK(+/+) and CASK(+/-) mice in home cage detected by a force plate. f
Quantitation of locomotion observed on a force plate (area covered in 5 min/net distance traveled). Data are plotted as mean ± SEM; (* indicates
p < 0.05; n = 5). All locomotion experiments were performed on mice between 25-30 days of age
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CASK(+/-) mouse brain would result in the majority of sur-
viving cells being CASK-positive (Additional file 1: Figure
S7A,B,C). We tested this hypothesis by performing a
quantitative immunoblotting experiment from CASK(+/+)
and CASK(+/-) mouse brain homogenates. Total CASK
levels were reduced by ~ 50 % in the brain of CASK(+/-)
mice compared to the CASK(+/+) mice (Fig. 5a, b), but no
significant change was observed in the level of a synaptic
marker (synaptophysin) or a generic cell marker (ATP syn-
thase β subunit), demonstrating that CASK null cells are
equally viable in the brain of CASK(+/-) mice. These data
suggest that the observed microcephaly in CASK(+/-) mice
is not due to the cell-autonomous loss of CASK null cells.
CASK is an intracellular cytosolic protein and interacts
with mitochondrial proteins
CASK is thought to be either completely or mainly
membrane-anchored protein [21, 28]. Deletion of a
signaling molecule at the membrane may explain a non-
cell autonomous effect. We therefore decided to re-
examine the cellular localization of CASK to confirm its
presence at the membrane. We fractionated the wild-
type mouse brain and looked for the solubility of CASK
compared to PSD95, another MAGUK protein which is
known to be membrane anchored [28, 63]. As expected,
we found that PSD95 is completely membrane-anchored
and is solubilized only with deoxycholic acid treatment,
whereas a significant amount of CASK is also present in
the cytosolic fraction isolated from the mouse brain, indi-
cating that CASK is a soluble cytosolic protein (Fig. 5c). In
this regard our finding is consistent with a previous report
[28]. To further explore CASK’s cellular localization, we
performed a Triton X-114 phase separation experiment.
Triton X-114 solution is homogenous at 0 °C but sepa-
rates into a detergent and aqueous phase at 20 °C, allow-





















































































































Fig. 5 CASK is present in cytosol as a part of large protein complexes. a Western blot showing endogenous level of CASK, synaptophysin, ATP
synthase β subunit and tubulin from CASK(+/+) and CASK(+/-) mutant mice (n = 3). b Western blot quantitation in CASK(+/-) mice relative to CASK(+/+)
mice. Data is normalized to tubulin and expressed relative to wild-type levels. Bar graphs are plotted as mean ± SEM. (* indicates p < 0.05; n = 3). c
Wild-type mice brains were initially fractionated to separate synaptosomal and cytosolic fractions. The synaptosomal fraction was solubilized initially in
Triton X-100 and then in deoxycholic acid (DCA). Samples were blotted for the indicated antigen. d Wild-type mouse brain homogenate was
solubilized in Triton X-114 at 4 °C, samples were warmed up to 37 °C and centrifuged to separate into an aqueous phase, a detergent phase and a
pellet. Equal dilutions of each phase were blotted for the indicated proteins. e Aqueous phase (after Triton X-114 phase separation) from brain
containing CASK was carefully layered on a 10-40 % continuous glycerol gradient. Following ultracentrifugation, samples were blotted for CASK and
liprin-α3. Fig. also shows pure recombinant CASK. Arrows indicate the fractions where protein standards of 150 kDa and 460 kDa were observed. f
GST-pulldown assay performed from rat brain homogenates using either full-length GST-CASK or GST (negative control) immobilized on glutathione
resin. Synaptophysin (negative control); liprin α2 (positive control); ATPsynβ (ATP synthase β subunit); and IDH (isocitrate dehydrogenase)
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amphiphilic transmembrane proteins [6]. Since Triton X-
114 is a mild non-ionic detergent, it is unlikely to disrupt
strong interactions [6]. Interestingly, most of the CASK
protein partitioned in the aqueous phase indicating that
CASK is not tightly membrane-anchored and predomin-
antly a cytosolic protein (Fig. 5d). In contrast to CASK,
only a minor fraction of PSD95 is present in the aqueous
phase (Fig. 5d). These results suggest that a large fraction
of CASK protein may be cytosolic in the mouse brain, and
in this aspect CASK differs substantially from other
MAGUK proteins such as PSD95, which is tethered to the
membrane to orchestrate cell-to-cell signaling.
In Drosophila, it is known that CASK interacts with
different protein complexes in different cell types [44].
We therefore sought to determine if in the mammalian
brain, CASK is also part of large protein complexes. We
first expressed and purified full-length recombinant rat
CASK (rCASK). CASK is a monomeric protein based on
the gel exclusion chromatography experiments (data not
shown). After glycerol gradient centrifugation, the
rCASK (MW 120 kDa) protein was present in the sec-
ond fraction along with a 150 kDa standard marker, as
expected. Since rCASK migrates at ~ 120 kDa on SDS-
PAGE, this confirms that rCASK is a monomer. In con-
trast, a large portion of the mouse brain cytosolic CASK
sedimented in the fourth fraction along with a 460 kDa
marker, indicating that when in cytosol, CASK is likely a
part of a multi-protein complex (Fig. 5e). Surprisingly,
small amounts of CASK were found to sediment in all
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Fig. 6 CASK(+/-) mutant mice exhibit growth retardation and skeletal muscle metabolic defects. Comparison of (a) body weight, (b) percentage
lean mass, (c) percentage fat mass and (d) percentage fluid mass. All comparisons are presented as mean ± SEM, (* indicates p < 0.05; n = 5). e
Energy expenditure/fat-free mass/hr in a 24-h period from CASK(+/-) mice compared to sex-matched CASK(+/+) littermate control. Data is presented
as mean ± SEM (* indicates p < 0.05; n = 5). f Respiratory exchange ratio from CASK(+/-) mice compared to sex-matched CASK(+/+) littermate control.
Data is presented as mean ± SEM. g Fatty acid oxidation rate and (h) glucose oxidation rate measured in skeletal muscle homogenates from
CASK(+/+) and CASK(+/-) sex-matched littermate mice. Bar graphs are plotted as mean ± SEM. (* indicates p < 0.05; n = 5). All experiments were
performed on one month old mice
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e.g. liprin-α3 which displayed a well-defined sedimenta-
tion fraction indicating that the mouse brain CASK may
be present in many complexes with molecular weights
larger than 500 kDa (Fig. 5e).
Since CASK interacts with mitochondrial proteins in
Drosophila [44], we next sought to determine if CASK
also interacts with mitochondrial proteins in mammals.
Using immobilized full-length recombinant CASK pro-
tein covalently attached to AminoLink™ agarose resin,
we performed an affinity chromatography experiment
using rat brain lysate and identified several CASK-
interacting mitochondrial proteins from rat brain
(unpublished data). To test the specificity of these inter-
actions, we performed a pull-down assay with a GST
(glutathione-S-transferase)-tagged CASK and found that
CASK interacts with the mitochondrial ATP synthase β
subunit and isocitrate dehydrogenase (IDH) (Fig. 5f ).
CASK(+/-) heterozygous mice show aberrant metabolism
Since mitochondrial proteins co-precipitates with CASK
in Drosophila [44] and mice, we hypothesized that
CASK may play a role in regulating metabolism. To test
this hypothesis, we characterized the consequences of
CASK deletion on mitochondrial function and whole
body metabolism. Our results showed that the one-
month old CASK(+/-) mice weigh less (a small but statis-
tically significant difference) than the sex-matched litter-
mate controls (Fig. 6a), however there is no significant
change in their lean body mass, fat weight or fluid
weight, indicating an overall growth retardation (Fig. 6b,
c, d). Surprisingly, we also found that CASK(+/-) mice ex-
pend significantly more energy at rest (Fig. 6e), which is
likely attributable to ataxia and imbalance in these mice.
It is known that an increase in muscle movement in-
creases the respiratory exchange ratio (CO2 production/
O2 uptake) [49], so we next examined the respiratory ex-
change ratio (RER). The RER of CASK(+/-) mice was in-
distinguishable from the CASK(+/+) littermate controls,
despite an increased energy expenditure (Fig. 6 f ).
Because some studies indicate that CASK plays a role
in endocrine function such as insulin release [72], it is
important to consider the fact that an overall measure
of organism or organ metabolism may not be indicative
of CASK’s direct involvement in cellular metabolism.
We therefore examined the rate of metabolic fuel oxida-
tion in skeletal muscle homogenates isolated from
CASK(+/-) mice compared to the sex-matched CASK(+/+)
littermate controls. Interestingly, we observed that the
skeletal muscles from CASK(+/-) mice oxidize signifi-
cantly lower amounts of fatty acids (Fig. 6g) and glucose
(Fig. 6h) compared to the CASK(+/+) mice, suggesting
that CASK is involved in the regulation of cellular sub-
strate metabolism.
CASK regulates mitochondrial respiration and oxidative
metabolism
The human embryonic kidney 293 (HEK293) cells ex-
press CASK endogenously (Fig. 7a). To determine if
CASK regulates mitochondrial function, we performed
CASK knockdown experiments in HEK293 cells using
two different shRNAs (out of 5 shRNAs tested;
Additional file 1: Figure S8) that showed > 50 % reduc-
tion in CASK expression. Specifically, the shRNA 692
and shRNA 690 showed ~ 85 % and ~ 60 % CASK knock-
down respectively in HEK293 cells compared to the vector
transfected control cells (Fig. 7a, b and Additional file 1:
Figure S9A,B). Knocking down CASK expression using
shRNA 692 significantly reduced the number of HEK293
cells and increased lactate production (Fig. 7c, d). Total
cell respiration was measured using a conventional Clark
oxygen electrode [58], and was found to be significantly
reduced in CASK knockdown HEK293 cells compared to
the control cells (Fig. 7e). Moreover, expressing rat CASK
in CASK knockdown HEK293 cells rescued the defect in
respiration demonstrating the specificity of the phenotype
(Fig. 7e). The decrease in respiration and cell numbers
was also replicated using the shRNA 690 that showed >
50 % CASK knockdown, but not with other shRNAs (i.e
shRNAs 691, 693 and 694) that showed < 50 % CASK
knockdown indicating a dose dependency of this pheno-
type (Additional file 1: Figure S9). Taken together, these
results suggest that mammalian CASK is a regulator of
mitochondrial respiration.
Since the neonatal brain is highly susceptible to de-
fects in metabolism, we next examined the effects of
CASK deletion on oxidative metabolism in the brain.
We adopted the same strategy as in muscles by using
the brain homogenates to rule out any indirect effect/s
of CASK deletion. Whole brain homogenates have been
shown to exhibit a more tightly coupled respiration than
isolated mitochondria [62]; and we also recently found
that respiration can be measured more effectively from
whole brain homogenates [11]. The rate of endogenous
respiration in whole brain homogenates from CASK(+/-)
mice was significantly reduced (~25 % decrease) com-
pared to the CASK(+/+) brain homogenates (Fig. 7f ),
further suggesting that CASK is a regulator of mitochon-
drial respiration in the brain. Since glucose is the major
source of fuel in the brain, we next asked whether glu-
cose oxidation was altered in the brain of CASK(+/-)
mice. We found a significant reduction (~20 % decrease)
in the rate of glucose oxidation in CASK(+/-) mice brain
compared to the CASK(+/+) brain (Fig. 7g), suggesting
that CASK regulates oxidative metabolism in the brain.
Discussion
XLID affects males at a significantly higher rate than fe-
males because males have a single X-chromosome [50].
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In females, X-linked mutations create a mosaic brain
due to random X-inactivation, with ~ 50 % of brain cells
expressing the mutant gene. This results in a relatively
milder phenotype, as exemplified by the doublecortin
mutations [1]. Most CASK deletion mutation patients
are females, indicating that CASK expression is essential
in the majority of cells for adequate brain function.
CASK heterozygous deletion mutation patient pheno-
types have been classified as MICPCH or pontocerebel-
lar hypoplasia. Here, we demonstrated that cerebellar
hypoplasia associated with CASK mutations may not be
a local neuronal pathology. One possible explanation for
the disproportionate cerebellar hypoplasia could be the
time of onset of this disorder; CASK heterozygous dele-
tion mutations lead to aberrant postnatal brain growth
and since cerebellar growth is largely postnatal, it may
be affected disproportionately. In fact, it is known that
although nutritional deprivation during postnatal brain
development inhibits overall brain growth, it affects
cerebellum disproportionately [57].
Consistent with the notion that CASK is not involved in
core neuronal functions [3], we demonstrate that
neuronal-specific CASK deletion does not alter neuronal
migration or survival. Although the neuron-specific CASK
heterozygous knockout mice did not exhibit any major
























































































































































































































Fig. 7 Reduction of CASK expression in cells and brain reduces oxidative metabolism. a Representative Western blot showing endogenous CASK
expression in human embryonic kidney (HEK293-PLKO) cells as well as CASK knockdown in HEK293 cells using shRNA692 (HEK-692). b Quantitation of
CASK knockdown (KD) in HEK293 cells using shRNA692 (* indicates p < 0.05; n = 3) (WT =wildtype). c Hemocytometer cell count in CASK knockdown
(KD) HEK293 cells compared to wild-type control cells (WT). Bar graphs are plotted as mean ± SEM (n = 4; * indicates p < 0.05). d Lactate measurement
from the culture media of wild-type control (WT) or CASK knockdown (KD) HEK293 cells. Bar graphs are plotted as mean ± SEM (* indicates p < 0.05;
n = 3). e Total cellular respiration rate in CASK knockdown (KD) HEK293 cells and CASK knockdown HEK293 cells overexpressing recombinant rat CASK
protein (KD + CASK) compared to the wild-type control cells (WT). Respiration is normalized to total protein levels (n = 4; * indicates p < 0.05,
** indicates p < 0.01). f Oxygen consumption rate measured in brain homogenates isolated from one month old CASK(+/+) and CASK(+/-) mice.
Respiration rate is normalized to the total protein content (* indicates p < 0.05; n = 4). g Glucose oxidation rate measured in brain homogenates
isolated from CASK(+/+) and CASK(+/-) sex-matched littermate mice (* indicates p < 0.05; n = 4)
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exhibited pronounced growth retardation and epilepsy,
and both are symptoms of CASK-related syndromes.
Since, the CASK neuronal-null mutants are made on a
hypomorphic background, at present it is not possible to
specifically point out the consequences of deleting CASK
only from neurons. However, our data suggests that the
disruption of neuronal CASK function does contribute to
the overall CASK mutation-related phenotypes.
Phenotypes associated with CASK heterozygous dele-
tion mutation in humans may represent a cumulative
loss of CASK function in different brain cell types. Since
CASK interacts with multiple synaptic proteins, it is pre-
sumed to possess a synaptic function [52]. Our recent
proteomic screening experiments in Drosophila melano-
gaster confirms the synaptic protein interactions of
CASK, but also revealed a hitherto unknown interaction
of CASK with mitochondrial proteins [44]. In agreement
with our previous findings, we demonstrate here that
mammalian CASK also interacts with certain metabolic/
mitochondrial proteins. Since a significant amount of
CASK was found to be cytosolic in the mouse brain, we
speculate that these interactions may be transient and
taking place in the cytosol. Interestingly, the cytosolic
interaction and phosphorylation of nuclear encoded
mitochondrial proteins with other kinases have been
shown to affect their import into mitochondria [53]. Re-
ducing CASK expression in a cellular or animal model
alters mitochondrial function, including oxygen con-
sumption and fuel metabolism. Since the cell biological
role of neuroglial cells and neurons are considerably dif-
ferent, specific deletion of CASK in each cell type is
likely to produce different phenotypes. A metabolic
function of CASK could also explain the phenotypic dif-
ferences observed in multiple animal models of CASK
deficiency, including the vulval phenotype in worms and
a defective locomotion phenotype in flies, both of which
are known to be associated with abnormal metabolism
[12, 29]. In mammals, the high metabolic demand of the
growing neonatal brain could explain the lethality and
postnatal onset of microcephaly and cerebellar hypopla-
sia in cases of CASK deficiency. It is possible that the
species-specific phenotypic differences represent a differ-
ence in the metabolic requirements of each specific ner-
vous system rather than an evolutionary difference in
the molecular function of CASK.
How does a cell-autonomous metabolic function of
CASK translate into the reduction of cell numbers in a
non-cell-autonomous manner? Although it may be as-
sumed that a significant reduction in the mitochondrial
function would be deleterious to the survival of neurons,
the extent to which the energetic function is compro-
mised may further determine whether neurons may sur-
vive abnormally or undergo cell death. In human
mitochondrial encephalopathies, the symptoms typically
do not manifest until two years of age, indicating ad-
equate survival of neurons during development [15]. Im-
portantly, the central nervous system pathology like
stroke episodes in mitochondrial encephalopathies may
also be related to an aberrant extracellular signaling e.g.
nitric oxide mediated signaling [15]. The non-cell au-
tonomous systemic manifestations of mitochondrial
stress are gradually getting recognized [32]. It is possible
that CASK deficiency modulates one or more metabolic
pathway/s which are critical for the secretion of a fac-
tor(s) essential for cellular survival. Conversely, it is also
possible that CASK deficiency leads to the release of
toxic intermediates, resulting in the loss of cells in a
non-cell autonomous manner. Mitochondrial function in
the brain is not only critical to ATP production but also
in regulating amino-acid metabolism, which governs
neurotransmitter production. An altered milieu of differ-
ent neurotransmitters in the brain may have profound
implications on neurodevelopment. It can therefore be
hypothesized that the postnatal microcephaly associated
with CASK heterozygous deletion mutation may be
caused by altered levels of one or more extracellular fac-
tors. Although much remains to be done to identify the
specific players involved, the most exciting aspect of this
study is the possibility that a metabolic intervention may
potentially prevent some of the postnatal consequences
associated with CASK deletion mutation.
Conclusions
Taken together our results suggest that lack of neuronal
CASK function contributes to the phenotypic spectrum
of CASK linked pathologies, however MICPCH is not
purely neuronal in origin. Therefore, constitutive hetero-
zygous CASK knockout females are better animal model
to investigate MICPCH. Our data further indicates that
although CASK is a cytosolic protein and may perform
cell-autonomous function in regulating metabolism,
CASK-linked microcephaly occurs in a non-cell autono-
mous manner which involves loss of both CASK positive
and CASK null cells. Finally, the observed cerebellar hy-
poplasia is not a local neuronal pathology; dispropor-
tionate cerebellar hypoplasia may simply represent
timing of the disorder which has a large postnatal com-
ponent. It is known that nutritional deprivation during
the postnatal brain growth spurt specifically affects the
cerebellum. Therefore, our findings also provide a valid
framework for the investigation of non-CASK related
cerebellar hypoplasia.
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